Pharmacotherapy in children and adolescents with obsessive-compulsive disorder.
This article examines the general principles of psychopharmacologic treatment of obsessive-compulsive disorder (OCD) in children and adolescents. It includes a description of the currently approved medications for the treatment of children and adolescents with OCD, their side effect profiles, approaches to refractory OCD, and a discussion of drug interactions. Future directions for research are also considered.
Grados
M
M
Department of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Scahill
L
L
Riddle
M A
MA
D000293:Adolescent; D002648:Child; D019468:Disease Management; D006801:Humans; D007167:Immunotherapy; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000628:therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D017367:Selective Serotonin Reuptake Inhibitors